Sg Americas Securities, LLC Oramed Pharmaceuticals Inc. Transaction History

Sg Americas Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$4.6 - $9.91 $166,345 - $358,365	-36,162 Reduced 77.71%	10,370 $67,000
Q2 2022 Jul 29, 2022	BUY	$3.72 - $9.0 $173,099 - $418,788	46,532 New	46,532 $213,000
Q1 2022 Apr 29, 2022	SELL	$8.19 - $13.89 $70,687 - $119,884	-8,631 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$12.98 - $29.75 $63,731 - $146,072	-4,910 Reduced 36.26%	8,631 $123,000
Q3 2021 Nov 01, 2021	BUY	$12.13 - $23.82 $164,252 - $322,546	13,541 New	13,541 $298,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.